Lumexa Imaging Holdings Statistics
Total Valuation
LMRI has a market cap or net worth of $1.78 billion. The enterprise value is $3.09 billion.
| Market Cap | 1.78B |
| Enterprise Value | 3.09B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
LMRI has 96.10 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 96.10M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.77 |
| Forward PS | n/a |
| PB Ratio | 10.64 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9,714.69 |
| P/OCF Ratio | 70.32 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 19.64, with an EV/FCF ratio of 16,889.86.
| EV / Earnings | n/a |
| EV / Sales | 3.08 |
| EV / EBITDA | 19.64 |
| EV / EBIT | 31.25 |
| EV / FCF | 16,889.86 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | 0.83 |
| Debt / Equity | 7.86 |
| Debt / EBITDA | 8.34 |
| Debt / FCF | 7,176.21 |
| Interest Coverage | 0.81 |
Financial Efficiency
Return on equity (ROE) is -26.01%.
| Return on Equity (ROE) | -26.01% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $246,893 |
| Profits Per Employee | -$10,697 |
| Employee Count | 4,064 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LMRI has paid $20.48 million in taxes.
| Income Tax | 20.48M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LMRI had revenue of $1.00 billion and -$43.47 million in losses. Loss per share was -$0.45.
| Revenue | 1.00B |
| Gross Profit | 137.02M |
| Operating Income | 115.07M |
| Pretax Income | -22.99M |
| Net Income | -43.47M |
| EBITDA | 157.41M |
| EBIT | 98.92M |
| Loss Per Share | -$0.45 |
Full Income StatementBalance Sheet
The company has $191,000 in cash and $1.31 billion in debt, giving a net cash position of -$1.31 billion or -$13.66 per share.
| Cash & Cash Equivalents | 191,000 |
| Total Debt | 1.31B |
| Net Cash | -1.31B |
| Net Cash Per Share | -$13.66 |
| Equity (Book Value) | 167.11M |
| Book Value Per Share | 1.74 |
| Working Capital | -14.08M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $25.28 million and capital expenditures -$25.10 million, giving a free cash flow of $183,000.
| Operating Cash Flow | 25.28M |
| Capital Expenditures | -25.10M |
| Free Cash Flow | 183,000 |
| FCF Per Share | $0.00 |
Full Cash Flow StatementMargins
Gross margin is 13.66%, with operating and profit margins of 11.47% and -4.33%.
| Gross Margin | 13.66% |
| Operating Margin | 11.47% |
| Pretax Margin | -2.29% |
| Profit Margin | -4.33% |
| EBITDA Margin | 15.69% |
| EBIT Margin | 9.86% |
| FCF Margin | 0.02% |